Is nutritional status a new indicator to use in clinical practice for colorectal cancer patients?
Rossana Berardi, Rebecca Chiariotti, Giulia Mentrasti, Department of Medical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Ancona 60126, Marche, Italy
Co-first authors: Rossana Berardi and Rebecca Chiariotti.
Author contributions: Berardi R, Chiariotti R, and Mentrasti G contributed to conception, design and manuscript writing.
Conflict-of-interest statement: Professor Rossana Berardi: Astra Zeneca, Advisory Board, Personal; Bayer, Advisory Board, Personal; Boehringer Ingelheim, Advisory Board, Personal; EISAI, Advisory Board, Personal; Incyte, Advisory Board, Personal; Lilly, Advisory Board, Personal; Menarini, Advisory Board, Personal; Merck, Advisory Board, Personal; MSD, Advisory Board, Personal; Gilead, Invited Speaker, Personal; Astra Zeneca, Funding, Institutional; Pfizer, Funding, Institutional; Roche, Funding, Institutional. The other authors indicated no financial relationships.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
https://creativecommons.org/Licenses/by-nc/4.0/ Corresponding author: Rossana Berardi, MD, PhD, Professor, Department of Medical Oncology, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Via Conca 71, Ancona 60126, Marche, Italy.
r.berardi@univpm.it
Received: April 30, 2024
Revised: June 20, 2024
Accepted: July 15, 2024
Published online: December 15, 2024
Processing time: 195 Days and 20.4 Hours
